BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10069949)

  • 41. Direct RNA binding by the rev product of HIV-1.
    Walley AJ; Heaphy S; Jones IM
    AIDS; 1989 Dec; 3(12):859-61. PubMed ID: 2517208
    [No Abstract]   [Full Text] [Related]  

  • 42. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.
    D'Agostino DM; Felber BK; Harrison JE; Pavlakis GN
    Mol Cell Biol; 1992 Mar; 12(3):1375-86. PubMed ID: 1545819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRNKL1 Is a Highly Selective Regulator of Intron-Retaining HIV-1 and Cellular mRNAs.
    Xiao H; Wyler E; Milek M; Grewe B; Kirchner P; Ekici A; Silva ABOV; Jungnickl D; Full F; Thomas M; Landthaler M; Ensser A; Überla K
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of cis-acting repressor activity within human immunodeficiency virus type 1 protease sequences.
    Huffman KM; Arrigo SJ
    Virology; 1997 Aug; 234(2):253-60. PubMed ID: 9268156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs.
    Campbell LH; Borg KT; Haines JK; Moon RT; Schoenberg DR; Arrigo SJ
    J Virol; 1994 Sep; 68(9):5433-8. PubMed ID: 8057425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm.
    Richard N; Iacampo S; Cochrane A
    Virology; 1994 Oct; 204(1):123-31. PubMed ID: 8091647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Control of human immunodeficiency virus type 1 RNA metabolism: role of splice sites and intron sequences in unspliced viral RNA subcellular distribution.
    Séguin B; Staffa A; Cochrane A
    J Virol; 1998 Dec; 72(12):9503-13. PubMed ID: 9811683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA.
    Ernst RK; Bray M; Rekosh D; Hammarskjöld ML
    Mol Cell Biol; 1997 Jan; 17(1):135-44. PubMed ID: 8972193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV-1 Rev function and RNA nuclear-cytoplasmic export.
    Cochrane A
    Methods Mol Biol; 2014; 1087():103-14. PubMed ID: 24158817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cellular HIV-1 Rev cofactor hRIP is required for viral replication.
    Yu Z; Sánchez-Velar N; Catrina IE; Kittler EL; Udofia EB; Zapp ML
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4027-32. PubMed ID: 15749819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three-dimensional structure of HIV-1 Rev protein filaments.
    Watts NR; Misra M; Wingfield PT; Stahl SJ; Cheng N; Trus BL; Steven AC; Williams RW
    J Struct Biol; 1998 Jan; 121(1):41-52. PubMed ID: 9573619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron.
    Hammarskjöld ML; Li H; Rekosh D; Prasad S
    J Virol; 1994 Feb; 68(2):951-8. PubMed ID: 8289397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the influence of subcellular localization of the HIV Rev protein on Rev-dependent gene expression by multi-fluorescence live-cell imaging.
    Wolff H; Hadian K; Ziegler M; Weierich C; Kramer-Hammerle S; Kleinschmidt A; Erfle V; Brack-Werner R
    Exp Cell Res; 2006 Feb; 312(4):443-56. PubMed ID: 16368434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrastructural localization of HIV-1 RNA and core proteins. Simultaneous visualization using double immunogold labelling after in situ hybridization and immunocytochemistry.
    Escaig-Haye F; Grigoriev V; Sharova I; Rudneva V; Buckrinskaya A; Fournier JG
    J Submicrosc Cytol Pathol; 1992 Oct; 24(4):437-43. PubMed ID: 1458433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 suppressive sequences are modulated by Rev transport of unspliced RNA and are required for efficient HIV-1 production.
    Noguchi K; Ishibashi K; Miyokawa K; Hokari M; Kanno T; Hirano T; Yamamoto N; Takaku H
    PLoS One; 2012; 7(12):e51393. PubMed ID: 23251516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation by HIV Rev depends upon recognition of splice sites.
    Chang DD; Sharp PA
    Cell; 1989 Dec; 59(5):789-95. PubMed ID: 2686839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of human immunodeficiency virus type 1 Rev function by a Rev mutant which interferes with nuclear/nucleolar localization of Rev.
    Kubota S; Furuta R; Maki M; Hatanaka M
    J Virol; 1992 Apr; 66(4):2510-3. PubMed ID: 1548775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes.
    Hope TJ; Klein NP; Elder ME; Parslow TG
    J Virol; 1992 Apr; 66(4):1849-55. PubMed ID: 1548742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of viral factors on subcellular distribution and RNA export activity of HIV-1 rev in astrocytes 1321N1.
    Banerjee A; Benjamin R; Banerjee S
    PLoS One; 2013; 8(9):e72905. PubMed ID: 24023789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm.
    Kalland KH; Szilvay AM; Langhoff E; Haukenes G
    J Virol; 1994 Mar; 68(3):1475-85. PubMed ID: 8107211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.